Concomitantly, Yan et al. reported that in cervical cancer cells, inhibition of the PI3K/Akt pathway reduces epithelial–mesenchymal transition (EMT) as well as cellular invasion and migration, providing a potentially valuable therapeutic target for cervical cancer (15). This evidence concerns the gene AKT1 and cervical cancer.